medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2014, Number 5

<< Back Next >>

Ann Hepatol 2014; 13 (5)

Updating the knowledge of hepatitis E: new variants and higher prevalence of anti-HEV in Argentina

Munné MS, Altabert NR, Otegui MLO, Vladimirsky SN, Moreiro R, Espul MP, Espul C, Manzur A, Soto SS, Brajterman LS, González JE

Language: English
References: 32
Page: 496-502
PDF size: 436.72 Kb.


ABSTRACT

Introduction. Hepatitis E is a disease of global distribution, with significant morbidity and mortality, whose scope and burden continue to emerge in low endemic countries. Material and methods. In 2012, we studied the prevalence of anti-HEV antibodies in 202 adult serum samples. We also analyzed samples from 143 patients with acute non-A-C hepatitis from January 2011 to December 2013. Acute HEV infections were diagnosed with anti-HEV IgM and/or HEV RNA. HEV RNA was also investigated in 94 swine fecal samples. HEV RNA was sequenced and characterized. Results. We found higher values of prevalence than those previously reported in the 1990s. The overall prevalence of anti-HEV IgG antibodies was 15.4%. The prevalence was 10.6% in the 123 adults voluntarily screened on World Hepatitis Day 2012 in Buenos Aires city and 14.8, 16.7 and 35.7% respectively in the smaller groups of healthcare workers, blood donors and HIV-positive patients from different regions of the country. Nine acute HEV infections were diagnosed in the three years analyzed. We characterized new human variants of subgenotype 3a and 3i. New subgenotype 3i variants were found in swine from two distant provinces closely related to the human ones. Conclusions. These results enlarge the knowledge of HEV and contribute with new information. However, higher values of prevalence found in small groups need to be confirmed in larger studies. Many aspects of the spectrum of the disease and the reservoirs and routes of transmission are still unknown and thus deserve additional research.


REFERENCES

  1. Riveiro-Barciela M, Rodríguez-Frías F, Buti M. Hepatitis E virus: new faces of an old infection. Ann Hepatol 2013; 12: 861-70.

  2. Kamar N, Bendall R, Legrand-Abravanel F, Xia NS, Ijaz S, Izopet J, Dalton HR. Hepatitis E. Lancet 2012; 379: 2477-88.

  3. Aggarwal R. Hepatitis E: Historical, contemporary and future perspectives. J Gastroenterol Hepatol 2011; 26 (Suppl. 1): 72-82.

  4. Hoofnagle JH, Nelson KE, Purcell RH. Hepatitis E. N Engl J Med 2012; 367: 1237-44.

  5. Echevarría JM, González JE, Lewis-Ximenez LL, Dos Santos DR, Munné MS, Pinto MA, Pujol FH, et al. Hepatitis E virus infection in Latin America: a review. J Med Virol 2013; 85: 1037-45.

  6. Schlauder GG, Frider B, Sookoian S, Castaño GC, Mushahwar IK. Identification of 2 novel isolates of hepatitis E virus in Argentina. J Infect Dis 2000; 182: 294-7.

  7. Munné MS, Vladimirsky S, Otegui L, Brajterman L, Castro R, Soto S, Moreiro R, et al. Molecular characterization of hepatitis E virus in three acute liver failure cases in children in Argentina. Acta Gastroenterol Latinoam 2006; 36: 125-30.

  8. Munné MS, Altabert NR, Vladimirsky SN, Moreiro R, Mares LO, Soto SS, Brajterman LS, et al. Identifications of polyphyletic variants in acute hepatitis suggest an underdiagnosed circulation of hepatitis E virus in Argentina. J Clin Virol 2011; 52: 138-41.

  9. Gruz F, Cleres M, Loredo D, Fernández MG, Raffa S, Yantorno S, Romero GA, et al. Hepatitis E: an infrequent virus or anunfrecuently investigated agent? Acta Gastroenterol Latinoam 2013; 43: 143-5.

  10. de Carvalho LG, Marchevsky RS, Dos Santos DR, de Oliveira JM, de Paula VS, Lopes LM, Van der Poel WH, et al. Infection by Brazilian and Dutch swine hepatitis E virus strains induces haematological changes in Macaca fascicularis. BMC Infect Dis 2013; 13: 495.

  11. Munné MS, Vladimirsky S, Otegui L, Castro R, Brajterman L, Soto S, Guarnera E, et al. Identification of the first strain of swine hepatitis E virus in South America and prevalence of anti-HEV antibodies in swine in Argentina. J Med Virol 2006; 78: 1579-83.

  12. Rey JA, Findor JA, Daruich JR, Velazco CC, Igartua EB, Schmee E, Kohan AI. Prevalence of IgG Anti-HEV in Buenos Aires, a Nonendemic Area for Hepatitis E. J Travel Med 1997; 4: 100-1.

  13. Fainboim H, González J, Fassio E, Martínez A, Otegui L, Eposto M, Cahn P, et al. Prevalence of hepatitis viruses in an anti-human immunodeficiency virus-positive population from Argentina. A multicentre study. J Viral Hepat 1999; 6: 53-7.

  14. Bendall R, Ellis V, Ijaz S, Ali R, Dalton H. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol 2010; 82: 799-805.

  15. Wenzel JJ, Preiss J, Schemmerer M, Huber B, Jilg W. Test performance characteristics of Anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates. J Infect Dis 2013; 207: 497-500.

  16. Inoue J, Takahashi M, Yazaki Y, Tsuda F, Okamoto H. Development and validation of an improved RT-PCR assay with nested universal primers for detection of hepatitis E virus strains with significant sequence divergence. J Virol Methods 2006; 137: 325-33.

  17. Fogeda M, Avellón A, Cilla CG, Echevarría JM. Imported and autochthonous hepatitis E virus strains in Spain. J Med Virol 2009; 81: 1743-9.

  18. Mansuy JM, Bendall R, Legrand-Abravanel F, Sauné K, Miédouge 1 M, Ellis V, Rech H, et al. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis 2011; 17: 2309-12.

  19. Keane F, Gompels M, Bendall R, Drayton R, Jennings L, Black J, Baragwanath G, et al. Hepatitis E virus coinfection in patients with HIV infection. HIV Med 2012; 13: 83-8.

  20. Mateos-Lindemann ML, Diez-Aguilar M, Galdamez AL, Galán JC, Moreno A, Pérez-Gracia MT. Patients infected with HIV are at high-risk for hepatitis E virus infection in Spain. J Med Virol 2014; 86: 71-4.

  21. Pas SD, Streefkerk RH, Pronk M, de Man RA, Beersma MF, Osterhaus AD, van der Eijk AA. Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients. J Clin Virol 2013; 58: 629-34.

  22. Abravanel F, Chapuy-Regaud S, Lhomme S, Miedougé M, Peron JM, Alric L, Rostaing L, et al. Performance of anti-HEV assays for diagnosing acute hepatitis E in immunocompromised patients. J Clin Virol 2013; 58: 624-8.

  23. Aggarwal R, Kini D, Sofat S, Naik SR, Krawczynski K. Duration of viraemia and faecal viral excretion in acute hepatitis E. Lancet 2000;356:1081-2.

  24. Scobie L, Dalton HR. Hepatitis E: source and route of infection, clinical manifestations and new developments. J Viral Hepat 2013; 20: 1-11.

  25. Baylis SA, Gärtner T, Nick S, Ovemyr J, Blümel J. Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States. Vox Sang 2012; 103: 89-90.

  26. Crossan C, Baker PJ, Craft J, Takeuchi Y, Dalton HR, Scobie L. Hepatitis E virus genotype 3 in shellfish, United Kingdom. Emerg Infect Dis 2012; 18: 2085-7.

  27. Brassard J, Gagné MJ, Généreux M, Côté C. Detection of human food-borne and zoonotic viruses on irrigated, fieldgrown strawberries. Appl Environ Microbiol 2012; 78: 3763-6.

  28. Maunula L, Kaupke A, Vasickova P, Söderberg K, Kozyra I, Lazic S, van der Poel WH, et al. Tracing enteric viruses in the European berry fruit supply chain. Int J Food Microbiol 2013; 15; 167: 177-85.

  29. Krog JS, Breum SØ, Jensen TH, Larsen LE. Hepatitis E virus variant in farmed mink, Denmark. Emerg Infect Dis 2013; 19: 2028-30.

  30. Gonzalez J, Fay O, Canero-Velasco MC, Fernandez E, Carchio E, Moreiro R, Weller C, et al. Hepatitis A virus infection in children in Argentina: a pilot study. Acta Gastroenterol Latinoam 1997; 27: 331-4.

  31. Vizzotti C, González J, Gentile A, Rearte A, Ramonet M, Cañero-Velasco MC, Pérez Carrega ME, et al. Impact of the single-dose immunization strategy against hepatitis A in Argentina. Pediatr Infect Dis J 2014; 33: 84-8.

  32. Zhang J, Shih JW, Wu T, Li SW, Xia NS. Development of the hepatitis E vaccine: from bench to field. Semin Liver Dis 2013; 33: 79-88.




2020     |     www.medigraphic.com